Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
EXPAREL and Bupivacaine
Pacira Ireland Limited
Postoperative Pain Management
1 trial -
EXPAREL and bupivacaine HCl
Pacira Ireland Limited
Postoperative Pain Management
1 trial -
Edoxaban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Valvular Atrial Fibrillation
1 trial -
Eicosapentaenoic acid monoglycerid (MAG-EPA)
Universal Integrated
Inflammation
1 trial -
Elaprase
Takeda
Hunter Syndrome
1 trial -
Elaprase for intravenous (IV) infusion
Takeda
Hunter Syndrome
1 trial -
Elaprase for intravenous (IV) infusion
Shire
Hunter Syndrome
1 trial -
Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets
The George Institute
Left ventricular thrombosis., Acute mycocardial infarction (AMI)
1 trial -
Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota, Double encapsulated oral transplant of fecal microbiota
Pari Pharma GmbH
Crohn’s disease
1 trial -
Engerix™ -B
GlaxoSmithKline
Hepatitis B
1 trial -
Entecavir + Placebo
ShuGuang Hospital
Liver Cirrhosis Due to Hepatitis B Virus
1 trial -
Entecavir+Fuzheng Huayu+TCM Granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Virus Related Cirrhosis
1 trial -
Enteric-Coated Mycophenolate Sodium (EC-MPS)
Novartis Pharmaceuticals
Renal Transplant
1 trial -
Epidiolex 100 mg/mL Oral Solution
Jazz Pharmaceuticals Ireland Limited
Dravet Syndrome (DS)
1 trial -
Epidyolex 100 mg/ml oral solution
Lacuna Pharma Pty Ltd
Tuberous Scerlosis Complex
1 trial -
Epinephrine (0.125 mg/inhalation)
Amphastar France Pharmaceuticals
Pharmacokinetics
1 trial -
Epirubicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Hepatocellular
1 trial -
Erythromycin 4% topical gel formulation
BRIGHT MINDS BIOSCIENCES INC.
Acne Vulgaris
1 trial -
Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection
The George Institute
Coronary artery chronic total occlusion
1 trial -
Evrysdi 0.75 mg/mL powder for oral solution, RO7034067
Hoffmann-La Roche
Spinal Muscular Atrophy (SMA)
1 trial -
Exparel
Pacira Ireland Limited
Analgesia, Postoperative
1 trial -
Exparel
Pacira Ireland Limited
Ankle Arthrodesis
1 trial -
Exparel
Pacira Ireland Limited
Laparotomy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources